ZOSTAVAX - 0006-4963-00 - (Zoster Vaccine Live)

Alphabetical Index


Drug Information of ZOSTAVAX

Product NDC: 0006-4963
Proprietary Name: ZOSTAVAX
Non Proprietary Name: Zoster Vaccine Live
Active Ingredient(s): 19400    [PFU]/.65mL & nbsp;   Zoster Vaccine Live
Administration Route(s): SUBCUTANEOUS
Dosage Form(s): INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of ZOSTAVAX

Product NDC: 0006-4963
Labeler Name: Merck Sharp & Dohme Corp.
Product Type: VACCINE
FDA Application Number: BLA125123
Marketing Category: BLA
Start Marketing Date: 20060525

Package Information of ZOSTAVAX

Package NDC: 0006-4963-00
Package Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4963-00) > .65 mL in 1 VIAL, SINGLE-DOSE (0006-4963-01)

NDC Information of ZOSTAVAX

NDC Code 0006-4963-00
Proprietary Name ZOSTAVAX
Package Description 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4963-00) > .65 mL in 1 VIAL, SINGLE-DOSE (0006-4963-01)
Product NDC 0006-4963
Product Type Name VACCINE
Non Proprietary Name Zoster Vaccine Live
Dosage Form Name INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route Name SUBCUTANEOUS
Start Marketing Date 20060525
Marketing Category Name BLA
Labeler Name Merck Sharp & Dohme Corp.
Substance Name VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
Strength Number 19400
Strength Unit [PFU]/.65mL
Pharmaceutical Classes Live Attenuated Varicella Zoster Virus Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Chickenpox Vaccine [Chemical/Ingredient],Live Attenuated Herpes Zoster Virus Vaccine [EPC],Herpes Zoster Vaccine [Chemical/Ingredient]

Complete Information of ZOSTAVAX


General Information